Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The product of P2RY2 belongs to the family of P2 receptors, which is activated by extracellular nucleotides and subdivided into P2X ligand-gated ion channels and P2Y G-protein coupled receptors. Additionally we are shipping P2RY2 Proteins (5) and P2RY2 Kits (2) and many more products for this protein.
Showing 10 out of 69 products:
Cat (Feline) Polyclonal P2RY2 Primary Antibody for EIA, WB - ABIN493185
Abbracchio, Burnstock: Purinoceptors: are there families of P2X and P2Y purinoceptors? in Pharmacology & therapeutics 1995
Show all 5 references for ABIN493185
Human Polyclonal P2RY2 Primary Antibody for EIA, WB - ABIN953967
Taboubi, Garrouste, Parat, Pommier, Faure, Monferran, Kovacic, Lehmann: Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration. in Molecular biology of the cell 2010
Show all 2 references for ABIN953967
Human Polyclonal P2RY2 Primary Antibody for IF (p), IHC (p) - ABIN755008
Liu, Kong, Jin, Gao, Qu, Zheng: Expression of the P2Y2 receptor in the terminal rectum of fetal rats with anorectal malformation. in International journal of clinical and experimental medicine 2015
expression of P2Y (show P2RY1 Antibodies)(2) receptor in peripheral sensory neurons that innervate the injured tissue and the activation of P2Y (show P2RY1 Antibodies) receptors contributes to mechanical allodynia following inflammation
In P2Y1R (-/-) mice, the expression of P2Y2 receptor in muscle was reduced by over 50 %, as compared to P2Y1R (+/+) mice.
P2Y2R deficiency does not alter baseline collateral vessel formation but does significantly impair collateral maturation, with resultant persistent limb ischemia despite enhanced angiogenesis.
P2Y2-/- mice are less susceptible to mount an autoimmune response against IRBP (show RBP3 Antibodies)
P2Y2 and Gq/G11 (show STK19 Antibodies) are required for basal endothelial NO formation, vascular tone, and blood pressure.
The data suggest that the P2Y2/4 receptor activation elicits blood pressure responses via distinct mechanisms involving KCa3.1 (show KCNN4 Antibodies) and Cx37 (show GJA4 Antibodies).
P2Y2-mediated increase of cytoplasmic Ca(2 (show CA2 Antibodies)+) concentration down-regulates the expression of NCC (show SLC12A3 Antibodies).
P2Y2 receptors play important roles in bone marrow cell differentiation and mineralization as well as in bone cell mechanotransduction, leading to an osteopenic phenotype in P2Y2 knockout mice.
P2Y2R has a role in the skin wound-healing process in mouse models
P2Y2 receptor fails to repress IL-6 (show IL6 Antibodies) expression by valve interstitial cells through Akt (show AKT1 Antibodies) in calcific aortic valve disease.
Data indicate that knockdown of caveolin-1 (Cav-1 (show CAV1 Antibodies)) expression causes redistribution of the P2Y2 nucleotide receptor (P2Y2R) from membrane rafts.
The P2RY2 receptor induces carcinoma cell migration and epithelial-mesenchymal transition through cross-talk with EGFR (show EGFR Antibodies).
Activation of P2Y2R increased TF promoter activity and mRNA expression in coronary artery endothelial cells.
Data show that the purinergic receptor P2Y2 (P2Y2R) pepducin activates neutrophils through formyl peptide receptor 2 (FPR2 (show FPR2 Antibodies)), and ATP is turned into an activating agonist through a receptor cross-talk mechanism that involves both FPR2 (show FPR2 Antibodies) and P2Y2R.
P2Y2 receptor and EGFR (show EGFR Antibodies) cooperate to promote prostate cancer cell invasion via ERK1/2 (show MAPK1/3 Antibodies) pathway.
These results indicate that B2R couples with P2Y2R and that these G-protein-coupled receptors act together to fine-tune cellular responsiveness.
These results suggest that over-activated ERK (show EPHB2 Antibodies) and PKC (show PRRT2 Antibodies) pathways are involved in the P2Y2R-mediated invasion of breast cancer cells.
P2Y2R may play an important role in cancer metastasis via modulation of the crosstalk between cancer cells and endothelial cells.
These results demonstrate that P2Y2R plays an important role in activation of the HIF-1alpha (show HIF1A Antibodies)-LOX (show LOX Antibodies) axis, the induction of collagen crosslinking and the recruitment of CD11b (show ITGAM Antibodies)+ hematopoietic bone marrow-derived cells.
the effect of ATP on Na+-ATPase (show DNAH8 Antibodies) activity could be involved in antinatriuresis induced by P2Y4 receptor (show P2RY4 Antibodies) or a mechanism to counterbalance the natriuretic effect of P2Y2 receptor, promoting fine control of sodium reabsorption in proximal tubule cells.
The product of this gene belongs to the family of P2 receptors, which is activated by extracellular nucleotides and subdivided into P2X ligand-gated ion channels and P2Y G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor, found on many cell types, is activated by ATP and UTP and is reported to be overexpressed on some cancer cell types. It is involved in many cellular functions, such as proliferation, apoptosis and inflammation. Three transcript variants encoding the same protein have been identified for this gene.
P2Y purinoceptor 2
, ATP receptor
, P2U purinoceptor 1
, P2U nucleotide receptor
, P2U receptor 1
, purinergic receptor P2Y2
, purinoceptor P2Y2
, P2Y ATP receptor 2
, P2Y2 nucleotide receptor